Keurig Dr Pepper (KDP) director buys 7,862 shares at $31.83

Rhea-AI Filing Summary

Keurig Dr Pepper Inc. (KDP) director Aaron E. Alt reported an open-market purchase of common stock. On August 25, 2026, he purchased 7,862 shares of KDP common stock at a weighted average price of approximately $31.83 per share, with individual trade prices ranging from $31.83 to $31.84. Following this transaction, Alt directly owns 7,862 KDP shares, as reported.

Insider Trade Summary

Net Buyer: 7,862 shares

Net Buy 1 txn

Insider Alt Aaron E

Role Director

Bought 7,862 shs ($250K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	7,862	$31.83	$250K

Holdings After Transaction: Common Stock — 7,862 shares (Direct)

Footnotes (1)

1. F1. The price represents the weighted average purchase price of the shares that were purchased in multiple transactions at prices ranging from $31.83 to $31.84. The reporting person undertakes to provide to the Company, any security holder of the Company or the SEC, upon request, full information regarding the number of shares purchased at each separate price.

Key Figures

Shares purchased: 7,862 shares of Common Stock Weighted average purchase price: $31.83 per share Purchase price range: $31.83 to $31.84 per share +1 more

4 metrics

Shares purchased 7,862 shares of Common Stock Open-market purchase by director Aaron E. Alt on August 25, 2026

Weighted average purchase price $31.83 per share Weighted average price for shares purchased on August 25, 2026

Purchase price range $31.83 to $31.84 per share Range of prices for multiple transactions making up the reported purchase

Shares owned after transaction 7,862 shares Direct holdings of Aaron E. Alt following the reported purchase

Key Terms

Form 4, weighted average purchase price, Rule 10b5-1

3 terms

Form 4 regulatory

"reported on this Form 4 as an open-market purchase of common stock"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

weighted average purchase price financial

"The price represents the weighted average purchase price of the shares"

The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.

Rule 10b5-1 regulatory

"The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did KDP director Aaron E. Alt report on this Form 4?

Aaron E. Alt reported an open-market purchase of 7,862 shares of Keurig Dr Pepper Inc. (KDP) common stock on August 25, 2026.

At what price did Aaron E. Alt buy KDP shares in this filing?

Aaron E. Alt bought KDP common stock at a weighted average purchase price of about $31.83 per share, with individual trades executed at prices ranging from $31.83 to $31.84.

How many KDP shares does Aaron E. Alt own after this reported transaction?

After the reported transaction, Aaron E. Alt directly owns 7,862 shares of Keurig Dr Pepper Inc. (KDP) common stock, according to the filing.

Was the KDP Form 4 transaction by Aaron E. Alt a purchase or a sale?

The Form 4 for Keurig Dr Pepper Inc. (KDP) shows that Aaron E. Alt executed a purchase transaction, acquiring 7,862 shares of KDP common stock in the open market.

Does the KDP Form 4 mention a Rule 10b5-1 trading plan for Aaron E. Alt?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan, and the footnote describes only the weighted average purchase price and price range for the multiple transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/27/2026 - 06:01 PM Accepted by SEC EDGAR 08/27/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alt Aaron E

(Last) (First) (Middle)

6425 HALL OF FAME LANE

(Street)

FRISCO TEXAS 75034

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Keurig Dr Pepper Inc. [ KDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2026		P		7,862	A	$31.83(1)	7,862	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price represents the weighted average purchase price of the shares that were purchased in multiple transactions at prices ranging from $31.83 to $31.84. The reporting person undertakes to provide to the Company, any security holder of the Company or the SEC, upon request, full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Jamie Friesen, attorney in fact	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)